Sanofi’s Infilbray Approved in US for Type 3 Gaucher Disease
The medicine was approved in the US as the first treatment for neurological manifestations of Type 3 Gaucher disease.
The medicine was approved in the US as the first treatment for neurological manifestations of Type 3 Gaucher disease.